Articles Archives - Page 2 of 758

MondayDec 22, 2025 9:45 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Closes Flow-Through Share Private Placement; All Set for Montauban Property Exploration

Disseminated on behalf of  ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., an exploration-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, just closed its non-brokered private placement of follow-through common shares, for aggregate gross proceeds of $4,505,000 These proceeds will help fund the exploration of its Montauban property in Quebec ESGold also engaged Atrium Research Corporation for research and publication of various reports on the investment case for ESGold, with services to run for 12 months ESGold (CSE: ESAU) (OTCQB: ESAUF), an exploration-stage company committed to acquiring, exploring, and…

MondayDec 22, 2025 9:00 am

Soligenix Inc. (NASDAQ: SNGX) Extends SGX302 Clinical Success in Phase 2A Psoriasis Study

Soligenix reported that SGX302 was well tolerated by all patients in cohort 3, with no drug-related adverse events identified during the treatment period. An optimized gel formulation was designed to improve the patient experience, with both easier dispensation and skin application. SGX302 utilizes visible light-activated synthetic hypericin, a first-in-class photodynamic therapy mechanism. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products for rare diseases where unmet medical need exists, announced extended top line results from its Phase 2a clinical trial of SGX302 (synthetic hypericin) in patients with mild-to-moderate psoriasis. The updated findings highlight clinical improvements with an optimized gel formulation…

FridayDec 19, 2025 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Advances Ricin Vaccine amid Toxin Threat

A recent report from India is a stark reminder of ricin’s accessibility and the pressing need for effective countermeasures. Ricin is a potent toxin capable of causing death within days of exposure because it stops protein synthesis inside cells, leading to organ failure. Soligenix has demonstrated meaningful preclinical efficacy for its ricin vaccine candidate. A recent “Times of India” report spotlighted the danger posed by ricin, a highly toxic plant-derived compound with no known antidote and a history of attempted misuse by extremist actors. Soligenix (NASDAQ: SNGX), a biopharmaceutical company focused on biodefense solutions, is developing a vaccine candidate known as RiVax(R) to protect against ricin…

FridayDec 19, 2025 9:45 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Completes 2025 Field Program at Atikokan REE Property

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. The field exploration program generated a substantial geological, geochemical, and radiometric dataset across multiple target areas. Mapping identified granitic and pegmatitic units considered favorable hosts for rare earth element mineralization. Radiometric surveys returned elevated readings that warrant further investigation, with pending assay results from 426 samples expected to guide next exploration steps. The companies increasing progress aligns with rising investor focus on securing non-Chinese rare earth supply chains. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company, has completed its 2025 field…

FridayDec 19, 2025 9:00 am

Safe Pro Group Inc. (NASDAQ: SPAI) Files Patent for the Company’s Computer Vision Technology Analysis Algorithm

The algorithm outlined in the patent application describes an approach to enhancing the detection precision and accuracy of AI when used to detect small objects in drone imagery. This patent filing is the latest in the company’s IP portfolio which includes other awarded and filed patents. Safe Pro Group has expanded international filings to protect the company’s IP rights in several countries and jurisdictions. Safe Pro Group (NASDAQ: SPAI), a developer of AI-powered security and defense solutions, recently announced the filing of the company’s most recent patent application (https://ibn.fm/G982Q). The patent is for Safe Pro’s AI-powered computer vision technology that…

ThursdayDec 18, 2025 10:30 am

Strawberry Fields REIT Inc. (NYSE American: STRW) CEO Highlights Discipline, Scale, and Steady Returns at NobleCon21

Chairman and CEO Moishe Gubin used his NobleCon21 presentation to outline Strawberry Fields REIT’s disciplined expansion strategy and long-term approach to healthcare real estate. The company now holds long-term leasehold interests in 142 healthcare facilities with more than 15,500 licensed beds across 10 states. Gubin emphasized a conservative acquisition philosophy, with each property evaluated from an operator’s perspective despite the company’s role as a self-administered REIT. The REIT has consistently collected 100% of rents and maintains long-term triple-net leases with 3% annual increases. Third-quarter 2025 results showed continued momentum, including rental income of $39.7 million and AFFO of $18.1 million.…

ThursdayDec 18, 2025 9:45 am

Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) Strengthens Indigenous, Community Partnerships to Support Responsible REE Development

A central pillar of Search Mineral’s commitment to the community is its long-standing partnership with the NunatuKavut Community Council The company further reinforces this partnership through its governance structure Search Minerals also maintains frequent dialogue with leaders in St. Lewis, Mary’s Harbour and Port Hope Simpson Disseminated on behalf of Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) and may include paid advertising. Search Minerals (TSX.V: SMY) (OTC: SHCMF) is advancing rare earth development in Labrador with a strong focus on community partnership, Indigenous engagement and responsible long-term stewardship. As the company advances work across its Critical Rare Earth Element (“CREE”)…

ThursdayDec 18, 2025 9:00 am

Insider Confidence and Record Results Highlight OptimumBank Holdings Inc. (NYSE American: OPHC) Momentum in South Florida

Director Michael Blisko’s open-market share purchase signals ongoing insider confidence in OptimumBank’s outlook. The Bank posted its strongest quarter on record in Q3 2025, with net earnings of $4.32 million and ROE of about 22.6%. Net interest margin expanded to 4.37%, supported by higher-yielding loans and disciplined funding costs. Assets topped $1.08 billion and deposits approached $960 million, extending multi-year growth trends. Management continues to emphasize relationship banking and selective expansion across South Florida. OptimumBank Holdings (NYSE American: OPHC), a community and business bank serving Florida, entered the final quarter of 2025 with a visible signal of internal confidence and…

WednesdayDec 17, 2025 9:45 am

Forward Industries Inc. (NASDAQ: FWDI) Gains Buy Rating as Solana-Focused Treasury Strategy Strengthens Outlook

Earlier this year, Forward Industries pivoted toward digital asset management, transforming into the world’s largest Solana-based DAT. The Oak Ridge report observes a notable expansion in institutional activity even amid the downturn in the crypto market. The report highlights the company’s rapid expansion of its digital infrastructure. Forward Industries (NASDAQ: FWDI) is the focus of a new analyst report from Oak Ridge Financial, which reiterates a Buy rating and establishes a $10 price target. The report highlights the company’s ongoing transformation into the world’s largest Solana-based Digital Asset Treasury (“DAT”) and evaluates why analysts believe the company may be positioned…

WednesdayDec 17, 2025 9:00 am

Oncotelic Therapeutics Inc. (OTLC) Leverages Nanoparticles to Re-Imagine Drug Delivery in Oncology

Research indicates that the advantages of nanoparticle delivery in pharma are significant Oncotelic Therapeutics has advanced nanoparticle-based delivery strategies through its joint venture entity, involving its Deciparticle platform Oncotelic is leveraging the very concepts of nanoparticle-mediated delivery in a real-world clinical context In the evolving landscape of pharmaceutical innovation, nanoparticles are rapidly transforming how we think about drug delivery, and Oncotelic Therapeutics (OTCQB: OTLC) is placing itself at the heart of that transformation by applying ultra-small carrier technologies to elevate existing cancer therapies. The company is pioneering how nanotechnology can enhance bioavailability, precision targeting and therapeutic performance of anticancer compounds.…

Site Search

Company Search

Category: Articles